{
    "2018-01-08": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Eli Lilly CEO Says Tax Reform May Lead to More Successful Deals",
                "features": {
                    "keywords": [
                        "Tax Reform",
                        "Successful Deals",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "R&D",
                        "Alzheimer's",
                        "Parkinson's",
                        "Cut Jobs"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Celgene deal could be the first of many for biopharma as new tax law frees up cash",
                "features": {
                    "keywords": [
                        "Celgene",
                        "deal",
                        "biopharma",
                        "tax law",
                        "cash"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biopharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Eli Lilly CEO: It's a great time for science in pharma",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "science",
                        "pharma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Alzheimer's takes Another Hit as Pfizer Ends Research in this Area",
                "features": {
                    "keywords": [
                        "Alzheimer's",
                        "Pfizer",
                        "Research"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Ozempic Could Boost Novo Nordiskâ€™s Revenue Growth in 2018",
                "features": {
                    "keywords": [
                        "Ozempic",
                        "Novo Nordisk",
                        "Revenue Growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Livongo and Lilly Collaborate on Real-World Diabetes Research",
                "features": {
                    "keywords": [
                        "Livongo",
                        "Lilly",
                        "Diabetes Research"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diabetes"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}